Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:ATCCode |
N05AX13
|
| gptkbp:CASNumber |
62613-82-5
|
| gptkbp:drugClass |
antipsychotic medication
benzamide derivative |
| gptkbp:hasMolecularFormula |
C17H19ClN2S
|
| https://www.w3.org/2000/01/rdf-schema#label |
D09950
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
dopamine D2 receptor antagonist
|
| gptkbp:molecularWeight |
318.86 g/mol
|
| gptkbp:PubChem_CID |
gptkb:DB00363
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
drowsiness
hypotension extrapyramidal symptoms |
| gptkbp:synonym |
Tiapride
|
| gptkbp:usedFor |
treatment of agitation in elderly
treatment of alcohol withdrawal treatment of dyskinesia |
| gptkbp:bfsParent |
gptkb:palbociclib
gptkb:ibrutinib |
| gptkbp:bfsLayer |
7
|